What is PureForm Global?
Headquartered in Los Angeles, California, PureForm Global is a biotechnology company dedicated to the research, development, and commercialization of synthesized CBD and other cannabinoids. Founded in 2016, the company utilizes a proprietary process to manufacture synthetic cannabinoids that are chemically identical to their plant-based counterparts. These compounds are produced at commercial scale in cGMP and FDA compliant facilities located in the US and UK, ensuring purity, consistency, and stability, free from THC, pesticides, and impurities. PureForm aims to supply high-quality cannabinoids to quality-conscious brands globally.
How much funding has PureForm Global raised?
PureForm Global has raised a total of $125K across 1 funding round:
Debt
$125K
Debt (2021): $125K with participation from PPP
What's next for PureForm Global?
With substantial late-stage funding and a recent strategic investment, PureForm Global is well-positioned for significant scaling and market expansion. The company's focus on producing synthesized cannabinoids at commercial scale, adhering to stringent cGMP and FDA standards, suggests a strategic push to capture a larger share of the premium cannabinoid market. Future developments are likely to involve further R&D into novel cannabinoid applications, expansion of manufacturing capabilities, and forging deeper partnerships with global brands seeking reliable, high-purity cannabinoid ingredients.
See full PureForm Global company page
